Credit: Janssen. Erleada (apalutamide), an androgen receptor inhibitor, is now available in a 240mg tablet. Erleada ® (apalutamide) is now available in a new 240mg tablet for the treatment of patients ...
Largest head-to-head real-world study in mCSPC demonstrated that ERLEADA ® reduced risk of death by 23 percent at 24 months compared to enzalutamide LISBON, Portugal, Oct. 2, 2024 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results